PT  - JOURNAL ARTICLE
AU  - Chassagnon, Guillaume
AU  - Vakalopoulou, Maria
AU  - Battistella, Enzo
AU  - Christodoulidis, Stergios
AU  - Hoang-Thi, Trieu-Nghi
AU  - Dangeard, Severine
AU  - Deutsch, Eric
AU  - Andre, Fabrice
AU  - Guillo, Enora
AU  - Halm, Nara
AU  - Hajj, Stefany El
AU  - Bompard, Florian
AU  - Neveu, Sophie
AU  - Hani, Chahinez
AU  - Saab, Ines
AU  - Campredon, Aliénor
AU  - Koulakian, Hasmik
AU  - Bennani, Souhail
AU  - Freche, Gael
AU  - Lombard, Aurelien
AU  - Fournier, Laure
AU  - Monnier, Hippolyte
AU  - Grand, Téodor
AU  - Gregory, Jules
AU  - Khalil, Antoine
AU  - Mahdjoub, Elyas
AU  - Brillet, Pierre-Yves
AU  - Ba, Stéphane Tran
AU  - Bousson, Valérie
AU  - Revel, Marie-Pierre
AU  - Paragios, Nikos
TI  - AI-Driven CT-based quantification, staging and short-term outcome prediction of COVID-19 pneumonia
AID  - 10.1101/2020.04.17.20069187
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.17.20069187
4099  - http://medrxiv.org/content/early/2020/04/22/2020.04.17.20069187.short
4100  - http://medrxiv.org/content/early/2020/04/22/2020.04.17.20069187.full
AB  - Chest computed tomography (CT) is widely used for the management of Coronavirus disease 2019 (COVID-19) 49 pneumonia because of its availability and rapidity1–3. The standard of reference for confirming COVID-19 relies on microbiological tests but these tests might not be available in an emergency setting and their results are not immediately available, contrary to CT. In addition to its role for early diagnosis, CT has a prognostic role by allowing visually evaluating the extent of COVID-19 lung abnormalities4, 5. The objective of this study is to address prediction of short-term outcomes, especially need for mechanical ventilation. In this multi-centric study, we propose an end-to-end artificial intelligence solution for automatic quantification and prognosis assessment by combining automatic CT delineation of lung disease meeting expert’s performance and data-driven identification of biomarkers for its prognosis. AI-driven combination of variables with CT-based biomarkers offers perspectives for optimal patient management given the shortage of intensive care beds and ventilators6, 7.Competing Interest StatementThe authors have declared no competing interest.Funding StatementN/AAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A